Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Bulgária

In Bulgária 10 Also abroad 559

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Dupnitsa, Haskovo, Plovdiv, Sofia, Stara Zagora, Veliko Tarnovo, Yambol
Életkor
40 év and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
2/3. fázisTaking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Dimitrovgrad, Haskovo, Pernik, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora, Veliko Tarnovo
Életkor
35 év to 80 év
People
1156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
3. fázisTaking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Dupnitsa, Haskovo, Pleven, Plovdiv, Ruse, Sofia, Sofiya, Stara Zagora, Veliko Tarnovo, Veliko Tirnovo, Vidin, Yambol
Életkor
40 év to 80 év
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
2. fázisNot yet taking people in Bulgária
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
Where
Sofiya
Életkor
18 év and over
People
183 worldwide
Run by
Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00
3. fázisTaking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Dupnitsa, Haskovo, Lovech, Montana, Pazardzhik, Pleven, Ruse, Sofia, Sofiya
Életkor
40 év to 80 év
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
3. fázisTaking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Burgas, Dupnitsa, Haskovo, Montana, Panagyurishte, Pazardzhik, Pernik, Pleven, Plovdiv, Ruse, Sandanski, Sevlievo, Sliven, Sofia, Stara Zagora, Varna, Vidin, Vratsa, Yambol, Medical center Fama Medical
Életkor
40 év to 80 év
People
5250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
2. fázisTaking people
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
Where
Dupnitsa, Haskovo, Plovdiv, Sofia, Stara Zagora, Veliko Tirnovo, Yambol
Életkor
18 év and over
People
307 worldwide
Run by
AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00
3. fázisTaking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Haskovo, Montana, Pleven, Ruse, Sofia, Sofiya
Életkor
40 év to 75 év
People
1196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
No phaseTaking people
Integrated Approach in Frail Older People with Atrial Fibrillation
Where
Haskovo, Pernik, Plovdiv, Sofia
Életkor
65 év and over
People
1250 worldwide
Run by
Heart Care Foundation
See details and how to joinNCT06775028
2. fázisNot yet taking people in Bulgária
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD
Where
Dupnitsa, Haskovo, Lovech, Pleven, Shumen, Sofiya
Életkor
40 év to 80 év
People
100 worldwide
Run by
Aer Therapeutics
See details and how to joinNCT06731959 · EU 2025-523020-50-00